{"id":"topical-prednisolone-acetate-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Elevated intraocular pressure"},{"rate":null,"effect":"Posterior subcapsular cataract formation"},{"rate":null,"effect":"Secondary ocular infection"},{"rate":null,"effect":"Ocular irritation or discomfort"},{"rate":null,"effect":"Blurred vision"}]},"_chembl":{"chemblId":"CHEMBL1697848","moleculeType":"Small molecule","molecularWeight":"486.61"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Prednisolone acetate reduces inflammation by inhibiting the release of inflammatory mediators, decreasing immune cell infiltration, and suppressing cytokine production at the ocular surface and anterior segment. The acetate ester formulation enhances corneal penetration compared to other prednisolone salts, allowing effective delivery of the active corticosteroid to intraocular tissues.","oneSentence":"Prednisolone acetate is a topical corticosteroid that suppresses local inflammatory and immune responses in the eye by binding to glucocorticoid receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:14.258Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammation and pain following ocular surgery"},{"name":"Steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye"},{"name":"Allergic conjunctivitis"},{"name":"Anterior uveitis"}]},"trialDetails":[{"nctId":"NCT07496060","phase":"PHASE4","title":"Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2025-08-10","conditions":"Anterior Chamber Granulomatous Uveitis","enrollment":66},{"nctId":"NCT06235567","phase":"PHASE1, PHASE2","title":"Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking","status":"ENROLLING_BY_INVITATION","sponsor":"Maanasa Indaram, MD","startDate":"2025-04-11","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT05626478","phase":"PHASE4","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery","status":"COMPLETED","sponsor":"Nicole Fram M.D.","startDate":"2023-06-01","conditions":"Corneal Edema, Corneal Defect, Anterior Chamber Inflammation","enrollment":50},{"nctId":"NCT07405489","phase":"","title":"Oral Prednisolone Versus Posterior Sub-Tenon Triamcinolone for Acute Ocular VKH","status":"COMPLETED","sponsor":"Benha University","startDate":"2021-01-01","conditions":"VKH Syndrome","enrollment":30},{"nctId":"NCT04371445","phase":"PHASE4","title":"Dextenza in the Post-op Management of Vitreoretinal Surgeries","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2020-06-01","conditions":"Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain","enrollment":30},{"nctId":"NCT05058287","phase":"PHASE3","title":"Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-11-05","conditions":"Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative","enrollment":150},{"nctId":"NCT07276802","phase":"PHASE4","title":"The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)","status":"NOT_YET_RECRUITING","sponsor":"Research Insight LLC","startDate":"2025-12-05","conditions":"Post Cataract Surgery","enrollment":40},{"nctId":"NCT05620901","phase":"EARLY_PHASE1","title":"DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia","status":"COMPLETED","sponsor":"Lejla Vajzovic, MD, FASRS","startDate":"2023-02-01","conditions":"Vitreoretinopathy, Coats' Disease, Exudative Retinopathy","enrollment":16},{"nctId":"NCT05023304","phase":"PHASE4","title":"In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery","status":"COMPLETED","sponsor":"Vance Thompson Vision","startDate":"2021-08-23","conditions":"Cataract","enrollment":30},{"nctId":"NCT05331664","phase":"PHASE4","title":"Dropless Pars Plana Vitrectomy Study","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2022-07-25","conditions":"Rhegmatogenous Retinal Detachment","enrollment":168},{"nctId":"NCT02205762","phase":"PHASE2, PHASE3","title":"LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis","status":"RECRUITING","sponsor":"North American Consortium for Histiocytosis","startDate":"2016-11-02","conditions":"Langerhans Cell Histiocytosis","enrollment":1400},{"nctId":"NCT05191706","phase":"PHASE4","title":"Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract","status":"RECRUITING","sponsor":"EyePoint Pharmaceuticals, Inc.","startDate":"2022-01-04","conditions":"Cataract","enrollment":60},{"nctId":"NCT06900907","phase":"NA","title":"Comparison of the Effects of Protocols Applied After Surgical Extraction of Impacted Mandibular Third Molars","status":"COMPLETED","sponsor":"Batman University","startDate":"2017-03-01","conditions":"Tooth Impaction | {Tooth} | Dental, Corticosteroid, Hyaluronic Acid","enrollment":75},{"nctId":"NCT03508440","phase":"PHASE2, PHASE3","title":"Intratympanic Steroid for Bell's Palsy","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2018-01-31","conditions":"Bell's Palsy, Facial Nerve Paresis","enrollment":10},{"nctId":"NCT05720715","phase":"PHASE4","title":"Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis","status":"COMPLETED","sponsor":"Farwaniya Hospital","startDate":"2022-01-01","conditions":"Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis","enrollment":30},{"nctId":"NCT04396990","phase":"PHASE4","title":"The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study","status":"COMPLETED","sponsor":"Vance Thompson Vision","startDate":"2020-06-08","conditions":"Refractive Surgery","enrollment":20},{"nctId":"NCT03920007","phase":"PHASE1, PHASE2","title":"Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D","status":"ACTIVE_NOT_RECRUITING","sponsor":"Atsena Therapeutics Inc.","startDate":"2019-09-12","conditions":"Leber Congenital Amaurosis, LCA, LCA1","enrollment":15},{"nctId":"NCT03484507","phase":"PHASE2","title":"Parasitic Ulcer Treatment Trial Pilot","status":"UNKNOWN","sponsor":"University of California, San Francisco","startDate":"2018-01-01","conditions":"Acanthamoeba Keratitis","enrollment":49},{"nctId":"NCT04200651","phase":"PHASE4","title":"Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery","status":"TERMINATED","sponsor":"The New York Eye Surgery Center","startDate":"2020-01-13","conditions":"Glaucoma, Cataract","enrollment":25},{"nctId":"NCT04184999","phase":"PHASE4","title":"Effect of Intraoperative Dexamethasone on Post-op Dry Eye","status":"COMPLETED","sponsor":"SR Cornea Consultants","startDate":"2019-08-10","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT02416128","phase":"NA","title":"Use of Topical Euphrasia, a Homeopathic Remedy in Ophthalmology","status":"WITHDRAWN","sponsor":"Larkin Community Hospital","startDate":"2015-04-30","conditions":"Iritis","enrollment":""},{"nctId":"NCT04464629","phase":"PHASE4","title":"Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment","status":"TERMINATED","sponsor":"Midwest Eye Institute","startDate":"2020-07-14","conditions":"Retinal Detachment","enrollment":7},{"nctId":"NCT04521140","phase":"PHASE4","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery","status":"COMPLETED","sponsor":"Nicole Fram M.D.","startDate":"2020-10-16","conditions":"Corneal Edema, Corneal Defect, Corneal Transplant","enrollment":36},{"nctId":"NCT04501367","phase":"PHASE4","title":"Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.","status":"UNKNOWN","sponsor":"Kovach Eye Institute","startDate":"2021-04-27","conditions":"Vitrectomy, Macular Pucker, Retinal Edema","enrollment":60},{"nctId":"NCT02798523","phase":"PHASE1","title":"Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-01-24","conditions":"Normal Physiology","enrollment":33},{"nctId":"NCT04479748","phase":"PHASE4","title":"DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses","status":"COMPLETED","sponsor":"Prism Vision Group","startDate":"2020-10-01","conditions":"Cataract","enrollment":13},{"nctId":"NCT04462523","phase":"PHASE4","title":"DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery","status":"COMPLETED","sponsor":"Patrick R. Oellers, MD","startDate":"2020-01-03","conditions":"Vitreo-Retinal Surgery","enrollment":40},{"nctId":"NCT04316936","phase":"PHASE4","title":"Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery","status":"COMPLETED","sponsor":"Silverstein Eye Centers","startDate":"2019-12-10","conditions":"Cataract Surgery","enrollment":15},{"nctId":"NCT05665270","phase":"PHASE4","title":"A Study for Post op Inflammation After Cataract Surgery","status":"UNKNOWN","sponsor":"Wyse Eyecare","startDate":"2023-01-30","conditions":"Cataract","enrollment":40},{"nctId":"NCT04563299","phase":"PHASE4","title":"Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections","status":"TERMINATED","sponsor":"Retina Vitreous Associates of Florida","startDate":"2020-12-09","conditions":"Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion","enrollment":10},{"nctId":"NCT05248139","phase":"NA","title":"Safety and Effectiveness of Drop-free Small Incision Cataract Surgery","status":"UNKNOWN","sponsor":"Visualiza","startDate":"2022-10","conditions":"Cataract, Ocular Inflammation, Ocular Hypertension","enrollment":100},{"nctId":"NCT04658927","phase":"PHASE4","title":"Dextenza With ILUX for Treatment of MGD","status":"COMPLETED","sponsor":"Warrenville Eyecare","startDate":"2021-01-04","conditions":"Meibomian Gland Dysfunction, Evaporative Dry Eye","enrollment":30},{"nctId":"NCT01941589","phase":"PHASE4","title":"Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2013-09","conditions":"Ulcerative Colitis","enrollment":149},{"nctId":"NCT04403516","phase":"PHASE4","title":"Dextenza in Pterygium Surgery","status":"COMPLETED","sponsor":"Michelle Rhee MD","startDate":"2020-10-01","conditions":"Pterygium","enrollment":30},{"nctId":"NCT05291793","phase":"NA","title":"The Effect of Different Intra-articular Injections Primary Gonarthrosis","status":"COMPLETED","sponsor":"Nevsehir Haci Bektas Veli University","startDate":"2020-04-01","conditions":"Gonarthrosis; Primary","enrollment":80},{"nctId":"NCT03626376","phase":"PHASE4","title":"Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2019-12-10","conditions":"Herpes Simplex Virus Keratitis","enrollment":""},{"nctId":"NCT04563559","phase":"PHASE2, PHASE3","title":"PREFERENTIAL Study","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2020-11","conditions":"Cataract Surgery, Glaucoma Surgery","enrollment":""},{"nctId":"NCT03779360","phase":"NA","title":"Intradermal LPS and Antibiotics","status":"COMPLETED","sponsor":"Centre for Human Drug Research, Netherlands","startDate":"2018-10-12","conditions":"Inflammation; Skin","enrollment":32},{"nctId":"NCT04273282","phase":"PHASE4","title":"A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%","status":"COMPLETED","sponsor":"Research Insight LLC","startDate":"2019-12-16","conditions":"Cataract","enrollment":31},{"nctId":"NCT02717871","phase":"PHASE3","title":"Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2016-03","conditions":"Keratitis; Infectious Disease (Manifestation)","enrollment":35},{"nctId":"NCT04549935","phase":"PHASE4","title":"The PRIME Study: A Randomized, Controlled, Prospective Study","status":"RECRUITING","sponsor":"Vance Thompson Vision - MT","startDate":"2020-09-14","conditions":"Patient Preference, Patient Outcomes, Post-Operative Inflammation","enrollment":20},{"nctId":"NCT00689078","phase":"PHASE4","title":"Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2008-05","conditions":"Allergic Conjunctivitis","enrollment":36},{"nctId":"NCT04451239","phase":"NA","title":"Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis","status":"UNKNOWN","sponsor":"Ameera Gamal Abdelhameed","startDate":"2020-06-30","conditions":"Keratonjunctivitis","enrollment":12},{"nctId":"NCT04426734","phase":"PHASE4","title":"Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids","status":"UNKNOWN","sponsor":"New England Retina Associates","startDate":"2020-07-01","conditions":"Non-infectious Anterior Uveitis","enrollment":30},{"nctId":"NCT04281862","phase":"PHASE4","title":"DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery","status":"UNKNOWN","sponsor":"Vance Thompson Vision","startDate":"2020-01-23","conditions":"Refractive Surgery","enrollment":20},{"nctId":"NCT03383328","phase":"PHASE4","title":"Study for Optimizing Anti-inflammatory Prophylaxis","status":"COMPLETED","sponsor":"Line Kessel","startDate":"2018-02-01","conditions":"Postoperative Cystoid Macular Edema, Irvine-Gass Syndrome","enrollment":470},{"nctId":"NCT04205916","phase":"PHASE4","title":"A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery","status":"RECRUITING","sponsor":"Ophthalmic Consultants of Long Island","startDate":"2019-11-04","conditions":"Patient Preference","enrollment":50},{"nctId":"NCT03693989","phase":"PHASE3","title":"Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-10-04","conditions":"Cataract","enrollment":178},{"nctId":"NCT00981435","phase":"PHASE4","title":"Steroids After Laser Trabeculoplasty for Glaucoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-09","conditions":"Glaucoma","enrollment":97},{"nctId":"NCT01475643","phase":"PHASE3","title":"Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-06","conditions":"Cataract","enrollment":107},{"nctId":"NCT01534195","phase":"PHASE4","title":"Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2012-01","conditions":"Allergic Conjunctivitis","enrollment":11},{"nctId":"NCT00493064","phase":"PHASE2, PHASE3","title":"To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions","status":"COMPLETED","sponsor":"Palo Alto Medical Foundation","startDate":"2006-10","conditions":"Retinal Vein Occlusion","enrollment":63},{"nctId":"NCT00324168","phase":"PHASE4","title":"Steroids for Corneal Ulcers Trial","status":"COMPLETED","sponsor":"Thomas M. Lietman","startDate":"2006-09","conditions":"Corneal Ulcer, Eye Infections, Bacterial","enrollment":500},{"nctId":"NCT01843920","phase":"NA","title":"The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble","status":"COMPLETED","sponsor":"Jason Hsu, MD","startDate":"2011-06","conditions":"Scleral Buckling","enrollment":21},{"nctId":"NCT00957801","phase":"PHASE4","title":"Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2009-03","conditions":"Sarcopenia","enrollment":29},{"nctId":"NCT01769352","phase":"PHASE2, PHASE3","title":"Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-08","conditions":"Post-surgical Cystoid Macular Edema (PSCME)","enrollment":42},{"nctId":"NCT02256969","phase":"PHASE4","title":"Intraductal Meibomian Gland Probing Trial","status":"COMPLETED","sponsor":"Joseph B. Ciolino, MD","startDate":"2014-10","conditions":"Meibomian Gland Dysfunction","enrollment":45},{"nctId":"NCT02412059","phase":"NA","title":"Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2015-08","conditions":"Epiretinal Membrane","enrollment":200},{"nctId":"NCT00345046","phase":"PHASE4","title":"A Comparison of Three Different Formulations of Prednisolone Acetate 1%","status":"COMPLETED","sponsor":"Indiana University School of Medicine","startDate":"2002-09","conditions":"Glaucoma, Cataract","enrollment":60},{"nctId":"NCT02279472","phase":"NA","title":"Optical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral Lridotomy","status":"UNKNOWN","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2014-10","conditions":"Primary Angle Closure Glaucoma","enrollment":40},{"nctId":"NCT02206789","phase":"NA","title":"Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection","status":"UNKNOWN","sponsor":"Aravind Eye Care System","startDate":"2012-02","conditions":"Corneal Graft Rejection","enrollment":200},{"nctId":"NCT01124045","phase":"PHASE3","title":"Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-08","conditions":"Cataracts, Inflammation","enrollment":80},{"nctId":"NCT00833495","phase":"PHASE2","title":"Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation","status":"COMPLETED","sponsor":"Fovea Pharmaceuticals SA","startDate":"2009-01","conditions":"Allergic Conjunctivitis","enrollment":155},{"nctId":"NCT00865540","phase":"PHASE4","title":"Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies","status":"UNKNOWN","sponsor":"Clinica Oftamologica Zona Sul","startDate":"2009-03","conditions":"Cataract","enrollment":30},{"nctId":"NCT00744666","phase":"PHASE4","title":"IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids","status":"UNKNOWN","sponsor":"Hotel Dieu Hospital","startDate":"2008-09","conditions":"Vitreoretinal Disease, Ocular Hypertension","enrollment":70},{"nctId":"NCT00406042","phase":"NA","title":"The Role of Steroids Following Selective Laser Trabeculoplasty","status":"COMPLETED","sponsor":"West Virginia University","startDate":"2005-09","conditions":"Glaucoma","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":69,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Topical Pred Forte 1%"],"phase":"marketed","status":"active","brandName":"Topical Prednisolone Acetate 1%","genericName":"Topical Prednisolone Acetate 1%","companyName":"New England Retina Associates","companyId":"new-england-retina-associates","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prednisolone acetate is a topical corticosteroid that suppresses local inflammatory and immune responses in the eye by binding to glucocorticoid receptors. Used for Inflammation and pain following ocular surgery, Steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye, Allergic conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}